STTK Shattuck Labs Inc
469
$7.16
2.32%
| Watchers | 469 |
| 52-Wk Low | $1.33 |
| 52-Wk High | $11.76 |
| Market Cap | $348.55M |
| Volume | 112,221.00 |
| 52-Wk High | $11.76 |
| 52-Wk Low | $1.33 |
Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare ConferenceGlobe Newswire • about 2 months ago
AUSTIN, TX & DURHAM, NC, April 01, 2024 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion...
Share to Feed
This indicator may be signaling STTK's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...
This indicator may be signaling that STTK's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...
This indicator may be signaling STTK's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...
This indicator may be signaling that STTK's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...
Shattuck Labs, Inc. (NASDAQ:STTK Get Free Report) insider Stephen Stout sold 16,004 shares of the stock in a transaction on Wednesday, March 6th. The shares were sold at an average price of...
This indicator may be signaling that STTK's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
AUSTIN, TX and DURHAM, NC, March 04, 2024 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (Nasdaq: STTK), a clinical-stage biotechnology company pioneering the development of bifunctional fusion...
HC Wainwright reaffirmed their buy rating on shares of Shattuck Labs (NASDAQ:STTK Free Report) in a research report released on Friday morning, Benzinga reports. HC Wainwright currently has...